PSTX - Poseida Therapeutics Partners With Astellas: Worth Watching For Now
2024-05-30 08:15:34 ET
Summary
- Poseida Therapeutics is a biopharmaceutical company specializing in cell and gene therapies for cancer and genetic conditions.
- The company's proprietary gene editing and delivery platforms show potential for partnerships and future research agreements.
- Hence, Poseida's gene editing platform should be considered the main value driver rather than specific drug candidates.
- While the company has a promising partnership with Astellas, its fair valuation and somewhat unproven IP limit its investment appeal.
...
Poseida Therapeutics Partners With Astellas: Worth Watching For Now